Of Outdoor Pursuit 40 Years DNA FORWARD-LOOKING STATEMENTS This presentation includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 as contained in Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements in this presentation include, but are not limited to, our ability to more efficiently manage inventory, our ability to win profitable growth across our leading pursuits, our ability t ...

Findings of Investigation by the Special Investigation Committee March 31, 2026 Toshiya Natori, Attorney-at-law, SHIN MARUNOUCHI LAW FIRM Tomohiro Hen, Attorney-at-law, Nagashima Ohno & Tsunematsu Yasunori Sato, Certified Public Accountant, Deloitte Tohmatsu LLC Outline of Investigation (1) The Special Investigation Committee (the "Committee") was retained by KDDI on January 14, 2026 to investigate the circular transactions lacking substance at BIGLOBE and G-PLAN (the "Fictitious Circular Transactions"). ◼ ...

MOL Group Corporate Management Plan Taking the leap to becoming a global social infrastructure company March 31, 2026 © 2026 Mitsui O.S.K. Lines, Ltd. A bulk carrier equipped with the Wind Challenger, a hard sail wind-assisted propulsion system On to the Next Stage As a social infrastructure company with its origins in ocean transportation, the Mitsui O.S.K. Lines Group is committed to expanding its business fields while pursuing sustainable growth. Under the Group Corporate Management Plan "BLUE ACTION 203 ...

Astellas R&D Day Pioneering science to change tomorrow March 31, 2026 1 ©2026 ASTELLAS PHARMA INC. AND ITS AFFILIATES. Cautionary statement regarding forward-looking information In this material, statements made with respect to current plans, estimates, strategies and beliefs and other statements that are not historical facts are forward-looking statements about the future performance of Astellas Pharma. These statements are based on management's current assumptions and beliefs in light of the information c ...

Q1 2026 Supplemental Information Progress Financial Results March 30, 2026 Forward Looking Statements This presentation contains statements that are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Progress has identified some of these forward-looking statements with words like "believe," "may," "could," "would," "might," "should," "expect," "intend," "plan," "target," "anticipate" an ...

Fourth Quarter and Full Year 2025 Earnings March 30, 2026 Disclaimer The material that follows is a presentation ("Presentation") of information about Innventure, Inc. and its subsidiaries (together referred to herein as "Innventure," the "Company," "us," "our," or "we") as of the date of this presentation. The Presentation does not purport to contain all information that may be required or desired by a party interested in investigating the Company, its business or prospects, and it shall not be deemed to b ...

The Company's financial results for the fiscal quarter and fiscal year ended January 31, 2026 reflect inclusion of the business operations of AccessOne from November 12, 2025. The post-acquisition results reflect only a partial period and include integration-related costs and therefore are not indicative of AccessOne's full-quarter or full-year performance. Investor Presentation FOURTH QUARTER | FISCAL YEAR 2026 Disclaimer This presentation includes express or implied statements that are not historical fact ...

This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. We intend such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act of 1933, as amended (the "Securities Act") and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). All statements contained in this presentation other than statements of historical fact ...

Delivering the Future of Genomic Medicines March 30, 2026 Forward-Looking Statements and Legal Disclaimers This presentation, and accompanying oral commentary, contains forward-looking statements regarding our current expectations. These forward-looking statements include, without limitation, statements relating to: the therapeutic and commercial potential and value of our product candidates and engineered capsids, including the ability of our zinc finger epigenetic regulators to address various neurologica ...

March 30th, 2026 4:30 PM Eastern Time Fourth Quarter & Year-end 2025 Operating & Financial Results Conference Call / Webinar NASDAQ :LTRN Forward Looking Statements This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements include, among other things, statements relating to: future events or our future financial performance; the potenti ...